Aspire Biopharma Holdings, Inc. reported on January 26, 2026, that it sold debentures worth $2,173,913.04 for $2,000,000 with a maturity date of April 23, 2026, to pay off debt and for working capital. The debentures do not bear annual interest and were issued as part of a Securities Purchase Agreement.